Brief: Acorda Therapeutics Reports Third Quarter 2022 Financial Results
01/11/2022 21:17
Nov 1 (Reuters) - Acorda Therapeutics Inc ACOR.O :
* ACORDA THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
* ACORDA THERAPEUTICS INC - 2022 GUIDANCE REAFFIRMED, 2023
THROUGH
2027 GUIDANCE PROVIDED
* ACORDA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.57
Source text for Eikon: ID:nBw7vhbJna
Further company coverage: ACOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acorda Therapeutics
See all newsBrief: Acorda TherapeuticsCourt Held Hearing To Consider Approval Of Sale Of Substantially All Of Co's Assets To Merz Pharmaceuticals Under Asset Sale
Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings
Live Markets: Biotech companies in 'Darwinian' world as cash remains king
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease (updated)
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease